524669 Stock Overview
Hester Biosciences Limited manufactures and trades in veterinary vaccines and animal health products in India and internationally.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 1/6 |
| Financial Health | 2/6 |
| Dividends | 3/6 |
Hester Biosciences Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₹1,630.30 |
| 52 Week High | ₹1,928.45 |
| 52 Week Low | ₹1,292.90 |
| Beta | 0.54 |
| 1 Month Change | 17.41% |
| 3 Month Change | 8.52% |
| 1 Year Change | -8.63% |
| 3 Year Change | -23.59% |
| 5 Year Change | 11.45% |
| Change since IPO | 39,027.21% |
Recent News & Updates
Recent updates
Shareholder Returns
| 524669 | IN Biotechs | IN Market | |
|---|---|---|---|
| 7D | 2.6% | -3.8% | -2.5% |
| 1Y | -8.6% | 15.5% | 44.5% |
Return vs Industry: 524669 underperformed the Indian Biotechs industry which returned 15.5% over the past year.
Return vs Market: 524669 underperformed the Indian Market which returned 44.5% over the past year.
Price Volatility
| 524669 volatility | |
|---|---|
| 524669 Average Weekly Movement | 4.2% |
| Biotechs Industry Average Movement | 6.1% |
| Market Average Movement | 6.9% |
| 10% most volatile stocks in IN Market | 10.1% |
| 10% least volatile stocks in IN Market | 4.3% |
Stable Share Price: 524669 has not had significant price volatility in the past 3 months.
Volatility Over Time: 524669's weekly volatility (4%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1987 | 693 | Rajiv Gandhi | www.hester.in |
Hester Biosciences Limited manufactures and trades in veterinary vaccines and animal health products in India and internationally. It operates through Poultry Healthcare, Animal Healthcare, and Petcare, and Others segments. The company provides poultry vaccines for newcastle disease, infectious bronchitis, infectious bursal disease, fowl pox, fowl typhoid, egg drop syndrome, reo, marek’s disease, infectious coryza, fowl cholera, mycoplasma gallisepticum, inclusion body hepatitis, avian coccidiosis, and avian encephalomyelitis.
Hester Biosciences Limited Fundamentals Summary
| 524669 fundamental statistics | |
|---|---|
| Market cap | ₹13.82b |
| Earnings (TTM) | ₹184.70m |
| Revenue (TTM) | ₹2.99b |
75.1x
P/E Ratio4.6x
P/S RatioIs 524669 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 524669 income statement (TTM) | |
|---|---|
| Revenue | ₹2.99b |
| Cost of Revenue | ₹996.67m |
| Gross Profit | ₹2.00b |
| Other Expenses | ₹1.81b |
| Earnings | ₹184.70m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
May 30, 2024
| Earnings per share (EPS) | 21.71 |
| Gross Margin | 66.69% |
| Net Profit Margin | 6.17% |
| Debt/Equity Ratio | 93.8% |
How did 524669 perform over the long term?
See historical performance and comparison